INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,818
+0.6%
3980.0%0.00%
Q2 2023$2,802
-15.6%
3980.0%0.00%
-100.0%
Q1 2023$3,319
-27.4%
3980.0%0.00%0.0%
Q4 2022$4,569
-8.6%
3980.0%0.00%0.0%
Q3 2022$5,000
+25.0%
398
-0.5%
0.00%0.0%
Q2 2022$4,000
-42.9%
4000.0%0.00%0.0%
Q1 2022$7,000
+16.7%
4000.0%0.00%0.0%
Q4 2021$6,0000.0%4000.0%0.00%0.0%
Q3 2021$6,0000.0%4000.0%0.00%0.0%
Q2 2021$6,000
+50.0%
4000.0%0.00%0.0%
Q1 2021$4,000
+33.3%
4000.0%0.00%0.0%
Q4 2020$3,000
+200.0%
4000.0%0.00%
Q3 2020$1,000
-50.0%
4000.0%0.00%
Q2 2020$2,000
+100.0%
4000.0%0.00%
Q1 2020$1,0000.0%4000.0%0.00%
Q4 2019$1,0000.0%4000.0%0.00%
Q3 2019$1,000
-50.0%
4000.0%0.00%
Q2 2019$2,000
-33.3%
4000.0%0.00%
-100.0%
Q1 2019$3,0000.0%4000.0%0.00%0.0%
Q4 2018$3,0000.0%4000.0%0.00%0.0%
Q3 2018$3,000
+50.0%
4000.0%0.00%
Q2 2018$2,0000.0%4000.0%0.00%
Q1 2018$2,0004000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders